Sanara MedTech Inc. — Form 8-K/A
Filed August 11, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 28/100
What the filing says
Sanara MedTech filed an amended 8-K/A on August 11, 2026 (amending prior disclosure from July 29, 2026) regarding Item 1.01 (entry into material definitive agreement) and Item 7.01 (Regulation FD disclosure). The filing document itself does not contain the substantive terms, counterparties, dollar amounts, dates, or nature of the agreement—only the structural metadata indicating a material definitive agreement was entered and amended disclosures were made. Specific financial terms and agreement details are not accessible in this filing header.
Why this rating
8-K/A amendment filing indicates a material agreement, but without disclosed terms (counterparty, amount, structure), scope cannot be assessed. Routine amended disclosure filing absent substantive detail.
Extracted items
- 1.01 material agreement
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.